Hyloris Pharmaceuticals (XBRU:HYL) Days Payable : 13,256.49 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Hyloris Pharmaceuticals Days Payable?

Hyloris Pharmaceuticals's average Accounts Payable for the six months ended in Dec. 2023 was €3.41 Mil. Hyloris Pharmaceuticals's Cost of Goods Sold for the six months ended in Dec. 2023 was €0.05 Mil. Hence, Hyloris Pharmaceuticals's Days Payable for the six months ended in Dec. 2023 was 13,256.49.

The historical rank and industry rank for Hyloris Pharmaceuticals's Days Payable or its related term are showing as below:

XBRU:HYL' s Days Payable Range Over the Past 10 Years
Min: 5275.21 Med: 9559.89 Max: 13610.08
Current: 11944.27

During the past 8 years, Hyloris Pharmaceuticals's highest Days Payable was 13610.08. The lowest was 5275.21. And the median was 9559.89.

XBRU:HYL's Days Payable is ranked better than
95.68% of 717 companies
in the Biotechnology industry
Industry Median: 147.29 vs XBRU:HYL: 11944.27

Hyloris Pharmaceuticals's Days Payable increased from Dec. 2022 (11,409.02) to Dec. 2023 (13,256.49). It may suggest that Hyloris Pharmaceuticals delayed paying its suppliers.

Hyloris Pharmaceuticals Days Payable Historical Data

The historical data trend for Hyloris Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyloris Pharmaceuticals Days Payable Chart

Hyloris Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

13,610.08

5,614.71

7,192.55

9,559.89

11,377.80

Hyloris Pharmaceuticals Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial							4,940.13	6,650.78	11,409.02	11,176.14	13,256.49

Competitive Comparison of Hyloris Pharmaceuticals's Days Payable

For the Biotechnology subindustry, Hyloris Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hyloris Pharmaceuticals's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hyloris Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Hyloris Pharmaceuticals's Days Payable falls into.

Hyloris Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Hyloris Pharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (2.302	+	3.496)	/	2 )	/	0.093	*	365
=	2.899					/	0.093	*	365
=	11,377.80

Hyloris Pharmaceuticals's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (3.332	+	3.496)	/	2 )	/	0.047	*	365 / 2
=	3.414					/	0.047	*	365 / 2
=	13,256.49

Hyloris Pharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of Hyloris Pharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Hyloris Pharmaceuticals (XBRU:HYL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hyloris Pharmaceuticals SA (XBRU:HYL) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

52U:Germany

Address

Boulevard Patience et Beaujonc N°3/1, Liege, BEL, 4000

Website

https://www.hyloris.com

Hyloris Pharmaceuticals SA is an early-stage specialty pharmaceutical company focused on adding value to the healthcare system by reformulating pharmaceuticals. The company develops proprietary products it believes offer advantages compared to available alternatives, to address the underserved medical needs of patients, hospitals, physicians, payors, and other stakeholders in the healthcare system. Its portfolio spans these areas such as Cardiovascular, Other Reformulations, and Established markets (high-barrier generics). It has two early commercial-stage products, Sotalol IV for the treatment of atrial fibrillation, and Maxigesic IV, a non-opioid analgesic product for the treatment of pain.